Q2 2024 · 13F-HR
Column Group LLCholdings as filed
Filed 2024-08-15 · accession 0000950123-24-008866
$71.3M
Reported value
6
Positions
2024-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 87990A106 | TNYA | Tenaya Therapeutics, Inc. | $29.1M | 40.9% | 9,400,290 | Common | SOLE |
| 68622P109 | ORIC | ORIC Pharmaceuticals Inc. | $25.0M | 35.1% | 3,540,777 | Common | SOLE |
| 86889P109 | — | Surrozen, Inc. | $8.9M | 12.4% | 810,088 | Common | SOLE |
| 75382E109 | — | RAPT Therapeutics Inc | $8.2M | 11.5% | 2,680,621 | Common | SOLE |
| 786700104 | SGMT | Sagimet Biosciences Inc. | $58,718 | 0.08% | 17,169 | Common | SOLE |
| 76155X100 | RVMD | Revolution Medicines Inc | $1,785 | 0.00% | 46 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.